Supply, implementation and support of PCR-based CFTR variant testing assays
- Published
- 23 April 2026
- Estimated value
- €1
- Place of performance
- IE061
- Procedure
- open
- Lots
- 1
- Notice number
- 00278581-2026
- Reference
- f2109ec4-2099-4aa2-ba30-44ce1db74005
- Official source
- Official source
CPV codes
- 33140000Material médico fungible
- 33124130Material para diagnóstico
- 33694000Medios de diagnóstico
- 33696500Reactivos de laboratorio
Description
We are seeking an assay for Cystic fibrosis (CF) and cystic fibrosis related disorders caused by pathogenic variants in the CFTR gene. The intended use of this assay is Genetic testing for: • Diagnostic confirmation • Carrier screening • Newborn screening (NBS) follow-up after elevated immunoreactive trypsinogen (IRT) results.
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Youregene Heath UK Ltd | €400,000 | — |
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is €1.
- Who is the buyer of this tender?
- The contracting authority is Children's Health Ireland (CHI) (European Union).
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.